The store will not work correctly when cookies are disabled.
4-(1,3-Thiazol-5-ylmethoxy)benzamide
ID: ALA5185078
PubChem CID: 142600514
Max Phase: Preclinical
Molecular Formula: C11H10N2O2S
Molecular Weight: 234.28
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)c1ccc(OCc2cncs2)cc1
Standard InChI: InChI=1S/C11H10N2O2S/c12-11(14)8-1-3-9(4-2-8)15-6-10-5-13-7-16-10/h1-5,7H,6H2,(H2,12,14)
Standard InChI Key: QVXUTHMJYRUHJT-UHFFFAOYSA-N
Molfile:
RDKit 2D
16 17 0 0 0 0 0 0 0 0999 V2000
-1.7102 0.4121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9956 0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2838 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2838 -0.4126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9938 -0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7102 -0.4163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9956 1.6496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7103 2.0622 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.2810 2.0622 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9938 -1.6496 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.2792 -2.0622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4353 -1.6496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4353 -0.8244 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.2395 -0.5743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7103 -1.2279 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2182 -1.8954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
2 7 1 0
7 8 2 0
7 9 1 0
5 10 1 0
10 11 1 0
11 12 1 0
13 12 1 0
13 14 1 0
14 15 2 0
16 15 1 0
12 16 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 234.28 | Molecular Weight (Monoisotopic): 234.0463 | AlogP: 1.82 | #Rotatable Bonds: 4 |
Polar Surface Area: 65.21 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.41 | CX LogP: 1.18 | CX LogD: 1.18 |
Aromatic Rings: 2 | Heavy Atoms: 16 | QED Weighted: 0.88 | Np Likeness Score: -1.36 |
References
1. Nizi MG, Maksimainen MM, Murthy S, Massari S, Alaviuhkola J, Lippok BE, Sowa ST, Galera-Prat A, Prunskaite-Hyyryläinen R, Lüscher B, Korn P, Lehtiö L, Tabarrini O.. (2022) Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15., 237 [PMID:35500474] [10.1016/j.ejmech.2022.114362] |